arrow
J

Johannes R. Bogner

university hospital of munich
H指数:44
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stability of the HIV cascade of care throughout the COVID-19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)

欧洲COVID-19大流行期间HIV治疗护理连续性稳定性:跨国EuroSIDA队列研究(2016–2022)的结果

2026-09-300
OAAI
Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+T cells

早期治疗和PD1抑制增强了滤泡性CD8+T细胞针对HIV的特异性功能

2025-04-080
OA
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial Human Immunodeficiency Virus Type 1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial
2025-03-010
PRE
Switch to fixed-dose doravirine (100 mg) with islatravir (075 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
2024-06-016
PRE
Characterization of cognitive symptoms in post COVID-19 patients

新型冠状病毒肺炎后患者认知症状的表征

2024-05-132
OAAI
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells
2024-04-010
OAAI
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications
2023-11-134
OAAI
Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years
2022-08-1111
OAAI
Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017 (vol 48, pg 723, 2020)
2021-08-030
OAAI
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017
2020-07-0111
OAAI
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1:100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies
2019-09-01102
PREAI
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment
2019-07-0215
OAAI